产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 询价 |
CAS No. |
1187594-14-4 |
|---|---|
中文名称 |
2-(3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-1-(环丙基磺酰基)氮杂环丁烷-3-基)乙腈 |
英文名称 |
2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile |
别名 |
WHO 11894 | 1187594-14-4 | UNII-N3TB5AH8B9 | ILUNOCITINIB [INN] | MS-26294 | 3-Azetidineacetonitrile, 1-(cyclopropylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)- | (1-(Cyclopropanesulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-py |
标准英文名 |
2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile |
分子式 |
C17H17N7O2S |
分子量 |
383.44 |
精确分子量 |
383.12 |
SMILES |
N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(C5CC5)=O)C1 |
标准SMILES |
N#CCC1(CN(C1)S(=O)(=O)C1CC1)N1C=C(C=N1)C1N=CN=C2NC=CC=12 |
性状 |
White to off-white powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
RVOUEXFKIYNODQ-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Inert atmosphere,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|